Silver Falcon Plc
("SILF" or "the Company")
Result of General Meeting
Silver Falcon Plc, (LSE: SILF), which has agreed to acquire the biotechnology company Hemogenyx Pharmaceuticals Limited ("Hemogenyx"), announces that following a General Meeting of the Company today all resolutions were duly approved by shareholders, including in relation to the waiver of Rule 9 of the Takeover Code and the Placing and Subscription.
Accordingly, the Acquisition and the related Placing and Subscription will complete tomorrow, 5 October 2017, subject only to the readmission of the enlarged share capital to the standard listing segment of the Official List and to trading on the main market for listed securities of the London Stock Exchange ("Admission"), which is expected to commence at 8.00 a.m. on 5 October 2017.
On Admission, the Company's total issued share capital will consist of 356,042,854 Ordinary Shares of £0.01 each. The Company holds no Ordinary Shares in treasury. The above figure (356,042,854) may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Hemogenyx Pharmaceuticals plc under the FCA's Disclosure Guidance and Transparency Rules.
The Company will trade under the new company name of Hemogenyx Pharmaceuticals Plc and the Company's new London Stock Exchange TIDM ticker symbol will be HEMO and its ISIN will remain as GB00BYX3WZ24.
In addition, the Company's new website address will be www.hemogenyx.com
Enquiries:
Hemogenyx Pharmaceuticals Limited |
||
Peter Redmond, Director |
Via Walbrook PR |
|
|
|
|
Optiva Securities Ltd |
Tel: +44 (0)20 3137 1902 |
|
Christian Dennis |
|
|
|
|
|
Shard Capital Partners LLP |
Tel: +44 (0)20 7186 9950 |
|
Damon Heath, Erik Woolgar |
|
|
|
|
|
Peterhouse Corporate Finance Limited |
Tel: +44 (0)20 7469 0930 |
|
Lucy Williams/Duncan Vasey |
|
|
|
|
|
Walbrook PR |
Tel: +44 (0)20 7933 8780 or hemogenyx@walbrookpr.com |
|
Paul McManus |
Mob: +44 (0)7980 541 893 |
|
|
|
|
Flowcomms IR |
Mob: +44 (0)7891 627 441 or sasha@flowcomms.com |
|
Sasha Sethi |
|
|